Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Superior vena cava obstruction

Palliative and end-of-life care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Airway or cerebral compromise from SVCO

Stridor, laryngeal oedema, severe respiratory distress, syncope, confusion, seizure or falling consciousness indicates critical venous obstruction or associated airway disease. Waiting for routine biopsy can be dangerous.

Action: Use ABCDE assessment, sit the patient upright, give oxygen for hypoxaemia and summon anaesthetic, respiratory, acute-oncology and interventional help. Obtain urgent contrast CT if stable enough, secure appropriate venous access and prioritise endovascular decompression or another immediately effective intervention while maintaining symptom relief.

Synopsis

Recognise impaired upper-body venous return, stabilise airway or cerebral compromise, define tumour and thrombus anatomy, preserve tissue diagnosis when safe and coordinate stenting, anticoagulation, radiotherapy, systemic treatment and symptom relief.

  • Superior vena cava obstruction causes facial, neck and arm swelling, venous distension, plethora, breathlessness, cough and headache that often worsen when lying flat or bending forward.
  • Stridor, laryngeal oedema, severe hypoxia, syncope, confusion or reduced consciousness indicates airway, cerebral or haemodynamic compromise and needs immediate senior intervention.
  • Cancer is the commonest cause, especially lung cancer and lymphoma, but central venous catheters and thrombosis increasingly cause benign or mixed obstruction.
  • First-line assessment uses ABCDE, seated positioning, oxygen only for hypoxaemia, focused venous and neurological examination and review of line, cancer, anticoagulant and bleeding history.
  • Contrast-enhanced CT of the chest with venous-phase definition is the key anatomical investigation; it shows level, length, collateral pathways, tumour, nodes and thrombus.
  • If the patient is stable and cancer has not been diagnosed, obtain tissue before radiotherapy or empirical corticosteroid because histology determines definitive treatment.
  • Endovascular stenting usually gives the fastest symptom relief in severe malignant obstruction and can be performed before histology when immediate decompression is necessary.
  • Fresh catheter-associated or bland thrombus may need anticoagulation and selected thrombolysis or thrombectomy; tumour compression requires cancer-specific systemic therapy or radiotherapy.
  • Corticosteroids are not routine treatment for every SVCO; consider them for steroid-sensitive lymphoma, marked tumour oedema or airway compromise with acute-oncology advice.
  • Document whether the goal is rapid symptom relief, disease response, durable venous patency or comfort alone and match procedure burden and aftercare accordingly.

Key red flags

Stridor, drooling, rapidly worsening hoarseness or inability to lie back suggests threatened upper airway.

Confusion, syncope, severe headache, vomiting, visual change or reduced consciousness suggests critical cerebral venous hypertension.

Severe hypoxaemia may reflect central airway obstruction, pleural disease, embolism or infection in addition to SVCO.

Abrupt unilateral arm and neck swelling around a central device raises fresh thrombosis that may be amenable to early intervention.

Hypotension or collapse is unusual in uncomplicated SVCO and should trigger a search for haemorrhage, sepsis, tamponade or embolism.

Empirical radiotherapy or corticosteroid before tissue can compromise lymphoma diagnosis when the patient is otherwise stable.

Upper-limb cannulation and high-volume infusion can worsen congestion or fail to reach the central circulation reliably.

Critical SVCO

Stridor, severe hypoxaemia, syncope, confusion, reduced consciousness or haemodynamic compromise requires immediate acute-oncology and airway or interventional support.

Investigation priorities

01
Immediate severity and airway assessmentFirst step

Record posture tolerance, oxygenation, stridor, voice, facial and limb swelling, venous pattern, cognition, syncope and haemodynamic state.

Management branches

Critical obstructionStabilise and decompress without delay

SVCO causes stridor, severe respiratory compromise, cerebral dysfunction or haemodynamic instability.

  1. Sit upright, use ABCDE care, give oxygen for hypoxaemia and involve airway, respiratory, acute-oncology and interventional specialists immediately.
  2. Obtain urgent contrast CT when safe and plan venous access and rescue around both caval and possible central-airway obstruction.
  3. Use endovascular stenting or another fastest effective intervention without waiting for routine histology, then secure tissue and disease treatment after stabilisation.
Stable malignant SVCOSecure diagnosis then match tumour treatment

Symptoms are significant but there is no airway, cerebral or circulatory emergency and malignancy is suspected.

  1. Perform contrast CT, stage immediate anatomy and obtain the least invasive adequate tissue before empirical radiotherapy or corticosteroid when feasible.
  2. Discuss stent for rapid relief versus systemic therapy or radiotherapy for tumour response, considering histology, symptom tempo, prior treatment, prognosis and preference.
  3. Provide upright symptom care and a named escalation route while treatment begins, with explicit review for worsening voice, breathing or cognition.

Key medicines

Anticoagulation for confirmed thrombotic obstructionChoose and dose low-molecular-weight heparin or another anticoagulant according to active cancer, renal and hepatic function, platelet count, bleeding risk, interactions and planned biopsy or stenting under the local cancer-associated thrombosis pathway.Anticoagulation does not rapidly remove fixed tumour compression; coordinate with intervention and avoid or modify during active bleeding, profound thrombocytopenia or incompatible goals.
Selective dexamethasone for oedematous tumourWhen acute oncology recommends treatment for steroid-sensitive lymphoma, marked tumour oedema or airway compromise, use the locally specified dexamethasone regimen and set an early response and taper review.It is not routine therapy for all SVCO and may reduce lymphoma biopsy yield; monitor glucose, infection, mental state and gastrointestinal risk.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UKONS acute oncology initial managementSeverity assessment, diagnosis and emergency management of superior vena cava obstruction.
  • NICE NG158 venous thromboembolic diseaseVenous thrombosis diagnosis and anticoagulant treatment principles.
  • CIRSE vena cava stenting informationStent procedure, expected symptom relief and procedural risks.
  • NICE NG12 suspected cancer referralUrgent pathways for lung, mediastinal and lymphoid malignancy presentations.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom